tyrosinemie [Tyrosinemias]

tematický
18
Termíny

4-hydroxyfenylpyruvátdioxygenasa - nedostatek
fumarylacetoacetasa - nedostatek
hereditární tyrosinemie
hypertyrosinemie
Richnerův-Hanhartův syndrom
tyrosinémie
tyrosinémie - typ I
tyrosinémie - typ II
tyrosinémie - typ III
tyrosinemie hepatorenální
tyrosinemie hereditární
tyrosinemie I. typu
tyrosinemie II. typu
tyrosinemie III. typu
tyrosinemie okulokutánní
tyrosintransaminasa - nedostatek

 

4 Hydroxyphenylpyruvate Dioxygenase Deficiency Disease
4-Hydroxyphenol Pyruvic Acid Oxidase Deficiency Disease
4-Hydroxyphenylpyruvate Dioxygenase Deficiency
4-Hydroxyphenylpyruvic Acid Oxidase Deficiency
Deficiency Disease, 4-Hydroxyphenol Pyruvic Acid Oxidase
Deficiency Disease, Fumarylacetoacetase
Deficiency Disease, Tyrosine Transaminase
Fumarylacetoacetase Deficiency
Fumarylacetoacetase Deficiency Disease
Hepatorenal Tyrosinemia
Hereditary Tyrosinemia, Type I
Hereditary Tyrosinemia, Type II
Hereditary Tyrosinemia, Type III
Hereditary Tyrosinemias
Hypertyrosinemia
Hypertyrosinemia, Type I
Keratosis Palmoplantaris with Corneal Dystrophy
Oregon Type Tyrosinemia
Richner-Hanhart Syndrome
Richner-Hanhart Syndrome, Tyrosinosis, Oculocutaneous Type
Tat Deficiency
Tyrosine Aminotransferase Deficiency
Tyrosine Transaminase Deficiency
Tyrosine Transaminase Deficiency Disease
Tyrosinemia
Tyrosinemia Type 1
Tyrosinemia, Type 2
Tyrosinemia, Type I
Tyrosinemia, Type II
Tyrosinemia, Type III
Tyrosinemias, Hereditary
Tyrosinosis, Oculocutaneous Type

Perzistentní odkaz   https://www.medvik.cz/link/D020176
Definice

Vrozená porucha metabolismu tyrosinu způsobená deficiencí fumarylacetoacetáthydrolázy, jejímž důsledkem je elevace hladiny tyrosinu v krvi a následné těžké poškození buněk jater, ledvin a CNS jeho metabolity (sukcinylaceton). Akutní forma se manifestuje do 6 měsíců života dítěte opožděným psychomotorickým vývojem, zvracením, průjmy a následně příznaky jaterního selhávání. Děti umírají na jaterní selhání do 2 let života. Chronická forma se manifestuje po 1. roce života neprospíváním, progresivní cirhózou, Fanconiho syndromem a vitamin D-rezistentní rachitidou. 40% dětí má akutní epizody polyneuropatie (hypertonie, paralytický ileus aj.). Děti umírají kolem 10. roku života. Patogenetický mechanismus této vady není znám. (cit. Velký lékařský slovník online, 2013 http://lekarske.slovniky.cz/ )

A group of disorders which have in common elevations of tyrosine in the blood and urine secondary to an enzyme deficiency. Type I tyrosinemia features episodic weakness, self-mutilation, hepatic necrosis, renal tubular injury, and seizures and is caused by a deficiency of the enzyme fumarylacetoacetase. Type II tyrosinemia features INTELLECTUAL DISABILITY, painful corneal ulcers, and keratoses of the palms and plantar surfaces and is caused by a deficiency of the enzyme TYROSINE TRANSAMINASE. Type III tyrosinemia features INTELLECTUAL DISABILITY and is caused by a deficiency of the enzyme 4-HYDROXYPHENYLPYRUVATE DIOXYGENASE. (Menkes, Textbook of Child Neurology, 5th ed, pp42-3)

Anotace
note X refs: consider also TYROSINE TRANSAMINASE /defic or other enzymes /defic
DUI
D020176 MeSH Prohlížeč
CUI
M0328654
Předchozí užití
Amino Acid Metabolism, Inborn Errors (1967-1999)
Historická pozn.
2000
Veřejná pozn.
2000

C Nemoci
C10.228.140 nemoci mozku 1 178
C10.228.140.163 metabolické nemoci mozku 84
C10.228.140.163.100.084 adrenoleukodystrofie 41
C10.228.140.163.100.320 galaktosemie 44
C10.228.140.163.100.355 Hartnupova nemoc 2
C10.228.140.163.100.360 hepatolentikulární degenerace 243
C10.228.140.163.100.362 dědičné demyelinizační nemoci CNS 11
C10.228.140.163.100.365 homocystinurie 107
C10.228.140.163.100.375 neketotická hyperglycinemie 7
C10.228.140.163.100.380 hyperlysinemie
C10.228.140.163.100.412 Leighova nemoc 26
C10.228.140.163.100.425 Leschův-Nyhanův syndrom 20
C10.228.140.163.100.520 nemoc s močí javorového sirupu 8
C10.228.140.163.100.535 syndrom MELAS 17
C10.228.140.163.100.540 Menkesova choroba 12
C10.228.140.163.100.545 syndrom MERRF 4
C10.228.140.163.100.593 nedostatek mevalonátkinázy 16
C10.228.140.163.100.640 okulocerebrorenální syndrom 9
C10.228.140.163.100.687 fenylketonurie 285
C10.228.140.163.100.725 nedostatek pyruvátkarboxylázy
C10.228.140.163.100.813 Refsumova nemoc 6
C10.228.140.163.100.844 Refsumova nemoc infantilní
C10.228.140.163.100.875 tyrosinemie 18
C10.228.140.163.100.937 vrozené poruchy cyklu močoviny 7
C10.228.140.163.100.968 Zellwegerův syndrom 10
C16.320.565.100.102 albinismus 17
C16.320.565.100.187 alkaptonurie 76
C16.320.565.100.477 neketotická hyperglycinemie 7
C16.320.565.100.480 hyperhomocysteinemie 212
C16.320.565.100.544 hyperlysinemie
C16.320.565.100.766 fenylketonurie 285
C16.320.565.100.794 nedostatek prolidázy
C16.320.565.100.823 propionová acidemie 3
C16.320.565.100.880 tyrosinemie 18
C16.320.565.189.084 adrenoleukodystrofie 41
C16.320.565.189.320 galaktosemie 44
C16.320.565.189.355 Hartnupova nemoc 2
C16.320.565.189.360 hepatolentikulární degenerace 243
C16.320.565.189.365 homocystinurie 107
C16.320.565.189.375 neketotická hyperglycinemie 7
C16.320.565.189.380 hyperlysinemie
C16.320.565.189.412 Leighova nemoc 26
C16.320.565.189.425 Leschův-Nyhanův syndrom 20
C16.320.565.189.535 syndrom MELAS 17
C16.320.565.189.540 Menkesova choroba 12
C16.320.565.189.545 syndrom MERRF 4
C16.320.565.189.593 nedostatek mevalonátkinázy 16
C16.320.565.189.640 okulocerebrorenální syndrom 9
C16.320.565.189.687 fenylketonurie 285
C16.320.565.189.813 Refsumova nemoc 6
C16.320.565.189.844 Refsumova nemoc infantilní
C16.320.565.189.875 tyrosinemie 18
C16.320.565.189.968 Zellwegerův syndrom 10
C18.452 metabolické nemoci 1 196
C18.452.132.100.084 adrenoleukodystrofie 41
C18.452.132.100.320 galaktosemie 44
C18.452.132.100.355 Hartnupova nemoc 2
C18.452.132.100.360 hepatolentikulární degenerace 243
C18.452.132.100.365 homocystinurie 107
C18.452.132.100.375 neketotická hyperglycinemie 7
C18.452.132.100.380 hyperlysinemie
C18.452.132.100.412 Leighova nemoc 26
C18.452.132.100.425 Leschův-Nyhanův syndrom 20
C18.452.132.100.535 syndrom MELAS 17
C18.452.132.100.540 Menkesova choroba 12
C18.452.132.100.545 syndrom MERRF 4
C18.452.132.100.593 nedostatek mevalonátkinázy 16
C18.452.132.100.640 okulocerebrorenální syndrom 9
C18.452.132.100.687 fenylketonurie 285
C18.452.132.100.813 Refsumova nemoc 6
C18.452.132.100.844 Refsumova nemoc infantilní
C18.452.132.100.875 tyrosinemie 18
C18.452.132.100.968 Zellwegerův syndrom 10
C18.452.648.100.102 albinismus 17
C18.452.648.100.187 alkaptonurie 76
C18.452.648.100.477 neketotická hyperglycinemie 7
C18.452.648.100.480 hyperhomocysteinemie 212
C18.452.648.100.544 hyperlysinemie
C18.452.648.100.766 fenylketonurie 285
C18.452.648.100.823 propionová acidemie 3
C18.452.648.100.880 tyrosinemie 18
C18.452.648.189.084 adrenoleukodystrofie 41
C18.452.648.189.320 galaktosemie 44
C18.452.648.189.355 Hartnupova nemoc 2
C18.452.648.189.360 hepatolentikulární degenerace 243
C18.452.648.189.365 homocystinurie 107
C18.452.648.189.375 neketotická hyperglycinemie 7
C18.452.648.189.380 hyperlysinemie
C18.452.648.189.412 Leighova nemoc 26
C18.452.648.189.425 Leschův-Nyhanův syndrom 20
C18.452.648.189.535 syndrom MELAS 17
C18.452.648.189.540 Menkesova choroba 12
C18.452.648.189.545 syndrom MERRF 4
C18.452.648.189.593 nedostatek mevalonátkinázy 16
C18.452.648.189.640 okulocerebrorenální syndrom 9
C18.452.648.189.687 fenylketonurie 285
C18.452.648.189.813 Refsumova nemoc 6
C18.452.648.189.844 Refsumova nemoc infantilní
C18.452.648.189.875 tyrosinemie 18
C18.452.648.189.968 Zellwegerův syndrom 10

Hawkinsinuria Disease MeSH Prohlížeč